Skip to main content
< Back
About
About the conference
Latest updates
Organisers & Partners
App
Press room
Programme 19
Full programme
Tracks
Speakers 19
Keynote speakers
All speakers
Side events 19
Venue 19
About the venue
Location
Rooms
Subscribe
Health consequences
Sessions
Plenary session
Poster session
Big debate
Structured session
Workshop
Oral presentation session
Short communication session
Poster guided tour
Cannabis
Alcohol and drug treatment
Health consequences
Opioid-related deaths: current and emerging lessons
Wednesday, 23 October
10:50
Cannabis beyond psychosis
10:50
to
12:20
Central square 1 (C1)
Maria de las Mercedes Balcells
Challenges for harm reduction I
10:50
to
12:20
Insights zone 2 (I2)
Meni Malliori
Definition of disorders
10:50
to
12:20
Networking zone 1 (N1)
Viktor Mravčík
Poster guided tour
Progress in alcohol research and responses - EUFAS poster session 1
10:50
to
12:20
Guided poster tours room
Colin Drummond
13:20
Poster guided tour
Problematic gaming and digital media use - ISSBA poster session 1
13:20
to
14:50
Guided poster tours room
Patrick Trotzke
Treatment — challenges, determinants and responses
13:20
to
14:50
Networking zone 3 (N3)
Dominique Lopez
Thursday, 24 October
09:00
Cannabis and causality — using multiple methods to unpick links between cannabis and neurobiology, cognition and mental health
09:00
to
10:30
Futures zone 3 (F3)
Suzanne Gage
Valentina Lorenzetti
10:50
Alcohol perspectives and prevention - EUFAS poster session 2
10:50
to
12:20
Guided poster tours room
Linn Gjersing
13:20
Injecting, risk and reducing harm
13:20
to
14:50
Networking zone 3 (N3)
Thomas Néfau
Alcohol: harms and policies
13:20
to
14:50
Futures zone 3 (F3)
Virginia Berridge
Focus on prescription drugs I
13:20
to
14:50
Insights zone 3 (I3)
Volker Auwärter
Reducing drug-related deaths
13:20
to
14:50
Central square 2 (C2)
Catherine Comiskey
The Reitox network poster session
13:20
to
14:50
Guided poster tours room
Nadine Berndt
15:00
Youth pathways
15:00
to
16:30
Networking zone 2 (N2)
Gregor Burkhart
Opioid-related deaths and other harms: current and emerging lessons - SSA poster session
15:00
to
16:30
Guided poster tours room
Sarah Welch
16:50
Results from a longitudinal UK general population cohort (ALSPAC)
Emerging health needs amongst adolescents who regularly use alcohol, cannabis or tobacco
16:50
to
18:20
Futures zone 2 (F2)
Jacqueline Vink
Methods and measurement of economic cost of substance use
16:50
to
18:20
Central square 3 (C3)
Rosalie Pacula
New methods
16:50
to
18:20
Central square 2 (C2)
André Noor
Friday, 25 October
10:45
Treatment — improving standards and outcomes
10:45
to
12:15
Networking zone 3 (N3)
Gerhard Bühringer
Presentations
Plenary session
Poster session
Big debate
Structured session
Workshop
Oral presentation session
Short communication session
Poster guided tour
Wednesday, 23 October
10:50
Poster
Exposure to alcohol and/or cadmium changes status of bioelements in rat tests
10:50
to
12:20
Guided poster tours room
Mirjana Djukic
Poster
'Drink to forget' – a case report
10:50
to
12:20
Guided poster tours room
Mariana Lázaro
Poster
Screening for alcohol-related cognitive impairments – a case study
10:50
to
12:20
Guided poster tours room
Luisa Gil
Poster
Neuroprotective role of argan oil against alcohol use disorders in adolescent wistar rat
10:50
to
12:20
Guided poster tours room
Hicham El Mostafi
Poster
Cadmium and/or ethanol increase oxidative stress in liver of the exposed rats
10:50
to
12:20
Guided poster tours room
Mirjana Djukic
Poster
Screening and brief interventions for reducing alcohol consumption in a department of firefighters in the central region of Portugal
10:50
to
12:20
Guided poster tours room
Teresa Barroso
Poster
Court proceedings and actions taken by a probation officer in work with people addicted to alcohol.
10:50
to
12:20
Guided poster tours room
Ewelina Silecka-Marek
Poster
Elderly wellbeing and alcohol - a tricky cocktail
10:50
to
12:20
Guided poster tours room
Jakob Emiliussen
Oral presentation
Impact of chronic cannabis use on physical health
10:50
to
12:20
Central square 1 (C1)
Hugo López-Pelayo
Oral presentation
Injury and cannabis use: Intentional and unintentional lesions
10:50
to
12:20
Central square 1 (C1)
Eugènia Campeny
Oral presentation
Cognitive functioning in cannabis users
10:50
to
12:20
Central square 1 (C1)
Oral presentation
Cerebellum and cannabis: research and clinical implications
10:50
to
12:20
Central square 1 (C1)
Chrysanthi Blithikioti
Oral presentation
Impact of cannabis use: integration of all research
10:50
to
12:20
Central square 1 (C1)
Laia Miquel
11:00
Oral presentation
Views about the disease and brain disease model of addiction: an international survey of addiction treatment providers in the USA, UK and Australia
11:00
to
11:15
Networking zone 1 (N1)
Anthony Barnett
Oral presentation
Vital signs: the future of the harm reduction model in the National Health Service
11:00
to
11:15
Insights zone 2 (I2)
Marta Borges
11:15
Oral presentation
Reconsidering cannabis dependence
11:15
to
11:30
Networking zone 1 (N1)
Liz Temple
Oral presentation
Harm reduction and public health: the case of Sweden
11:15
to
11:30
Insights zone 2 (I2)
Lena Eriksson
11:30
Oral presentation
Agreement degree with the content of the Substance Addiction Consequences Scale items - The development of a new instrument.
11:30
to
11:45
Networking zone 1 (N1)
Paulo Seabra
Oral presentation
Harm reduction drug policy in Israel: what has and still needs to be accomplished?
11:30
to
11:45
Insights zone 2 (I2)
Hagit Bonny-Noach
11:45
Oral presentation
Characterising people that demanded drug treatment in Catalonia: a cluster analysis
11:45
to
12:00
Networking zone 1 (N1)
Xavier Majó
Oral presentation
Street Support Project: a harm reduction approach to urban health and integration
11:45
to
12:00
Insights zone 2 (I2)
Roberto Pérez Gayo
13:20
Poster
The effectiveness of prevention programs for problematic usage of internet in adolescents and youths: a systematic review
13:20
to
14:50
Guided poster tours room
Silvana Romero
Poster
Obsessive compulsive disorder and internet gaming disorder
13:20
to
14:50
Guided poster tours room
Marisa Martins
Poster
Internet gaming: hobby or behavioral addiction?
13:20
to
14:50
Guided poster tours room
Ana Samouco
Poster
New addictions, new risks: sexting behaviours as a result of internet addiction
13:20
to
14:50
Guided poster tours room
Manuel Jesús Ruiz Muñoz
Poster
Cybersex, mental health and intimacy: an exploratory study with a population in treatment of substance use disorders
13:20
to
14:50
Guided poster tours room
Teodomiro Miguel B. F. Urbano Pires
Poster
Interrelationships between smartphone addiction, affect, sleep quality, and sexual problems: preliminary findings in a nonclinical female sample
13:20
to
14:50
Guided poster tours room
Rui Costa
Poster
Internet addiction is related to distortion of time perception assessed by the Perception of Time Online Scale (PTO)
13:20
to
14:50
Guided poster tours room
Rita de Sousa Lopes
Poster
The association of alexithymia and internet gaming disorder in a clinical German sample
13:20
to
14:50
Guided poster tours room
Magdalena Pape
Poster
Internet addiction correlates with online sexual behaviours
13:20
to
14:50
Guided poster tours room
Rui Costa
Poster
Gamification: Promoting healthy online behavior among 5-12 years children through a game
13:20
to
14:50
Guided poster tours room
Ivone Patrão
13:30
Short communication
Treating drug abuse and health issues in the criminal justice system. An empirical research on the linkage of health and criminal justice interventions, France
13:30
to
13:40
Networking zone 3 (N3)
Ivana Obradovic
Short communication
Perceptions on social determinants of opioid dependence recovery
13:30
to
13:40
Networking zone 3 (N3)
Leonor Brito
13:40
Short communication
Reverse transition from injecting to smoking heroin and/or crack cocaine on lower methadone dose: sub-therapeutic dosing or safer drug use?
13:40
to
13:50
Networking zone 3 (N3)
Felicia Heidebrecht
13:50
Short communication
Benzodiazepine management in primary care: barriers and facilitators
13:50
to
14:00
Networking zone 3 (N3)
Kristien Coteur
14:00
Short communication
Referral of European and third country non-national clients in Belgian drug treatment
14:00
to
14:15
Networking zone 3 (N3)
Eva Blomme
14:10
Short communication
HIV and drug abuse: relationship and treatment challenges
14:10
to
14:20
Networking zone 3 (N3)
Sara Dehanov
14:20
Short communication
Motivation for treatment predict adherence to treatment in a randomised clinical trial
14:20
to
14:30
Networking zone 3 (N3)
Zhanna Gaulen
14:30
Short communication
Psychiatric assessment of prisoners in opioid-maintenance treatment: emphasis on ADHD
14:30
to
14:40
Networking zone 3 (N3)
Marisa Silbernagl
14:40
Short communication
Perceptions on social determinants of opioid dependence recovery
14:40
to
14:50
Networking zone 3 (N3)
Thursday, 24 October
09:10
Oral presentation
Neurobiological changes predating and following cannabis use onset: findings from longitudinal neuroimaging studies
09:10
to
09:25
Futures zone 3 (F3)
Valentina Lorenzetti
09:25
Oral presentation
Transitions from use of cannabis to dependence, and comparisons with other substances
09:25
to
09:40
Futures zone 3 (F3)
Christina Marel
09:40
Oral presentation
Genetic liability for schizophrenia and patterns of tobacco and cannabis use in adolescence
09:40
to
09:55
Futures zone 3 (F3)
Oral presentation
Triangulating the evidence: exploring causality in the link between cannabis and mental health
09:40
to
09:55
Futures zone 3 (F3)
Suzanne Gage
10:50
Poster
Alcohol addiction as a social problem in Ukraine: history of research
10:50
to
12:20
Guided poster tours room
Larysa Klymanska
Poster
The alcohol consumption in the modern Ukraine: tendences and perspecties.
10:50
to
12:20
Guided poster tours room
Larysa Klymanska
Poster
Alcohol and drugs in contemporary school pupils on the verge of adolescence: the Polish experience
10:50
to
12:20
Guided poster tours room
Katarzyna Pawelek
Poster
The role of alcohol in fatal fires in Ireland
10:50
to
12:20
Guided poster tours room
Anne Doyle
Poster
Do parents want to change alcohol legislations to protect their children?
10:50
to
12:20
Guided poster tours room
Marta Zin-Sedek
Poster
Social and context determinants of drinking during working time – Portuguese GPS findings 2017
10:50
to
12:20
Guided poster tours room
Cláudia Urbano
Poster
Sub-groups of tobacco and alcohol co-use trajectories from ages 21 to 32: the Amsterdam growth and health longitudinal study
10:50
to
12:20
Guided poster tours room
Sterling McPherson
Poster
Effects of an alcohol prevention program at sport stadiums: a 2-year follow-up study using pseudopatrons and breath alcohol concentration levels
10:50
to
12:20
Guided poster tours room
Tobias Elgan
Poster
Implementing and evaluating alcohol and drug prevention methods at youth health clinics
10:50
to
12:20
Guided poster tours room
Pia Kvillemo
Poster
Accessing alcohol drinking influence in workplace – What is the panorama and current innovations in Portugal?
10:50
to
12:20
Guided poster tours room
Duarte Vital Brito
13:20
Poster
Trends on the Dutch drug market identified by DIMS in 2018
13:20
to
14:50
Guided poster tours room
Laura Smit-Rigter
Poster
Gendered sources of drug supply for recreational drug users in the European Web Survey on Drugs
13:20
to
14:50
Guided poster tours room
Michael Vuolo
Poster
Trends in primary substance mentioned by patients entering treatment for illicit substance use in Belgium between 2012 and 2018
13:20
to
14:50
Guided poster tours room
Antoine Jérôme
Poster
Criminal reactions and reduction of crime and drug use in drug-using offenders
13:20
to
14:50
Guided poster tours room
Olga Souza Cruz
Poster
Fatal traffic accidents in connection to driving under the influence of psychoactive substances
13:20
to
14:50
Guided poster tours room
Ada Hocevar Grom
Poster
HIV infection in drug users in harm reduction structures
13:20
to
14:50
Guided poster tours room
Isabel Ponte
Poster
Drug-related deaths and mortality in Europe
13:20
to
14:50
Guided poster tours room
Federica Mathis
Poster
Demand for drug treatment in Europe: the Treatment Demand indicator (TDI)
13:20
to
14:50
Guided poster tours room
Linda Montanari
Poster
Non-medical prescription drug use among Estonian adults
13:20
to
14:50
Guided poster tours room
Sigrid Vorobjov
Poster
Monitoring drug-related infectious diseases in Europe
13:20
to
14:50
Guided poster tours room
Thomas Seyler
Poster
Estimating the number of people who inject drugs (PWID) in Europe
13:20
to
14:50
Guided poster tours room
Thomas Seyler
13:30
Short communication
Nurse-delivered injection education and subsequent injection drug use practices among street-involved youth
13:30
to
13:40
Networking zone 3 (N3)
Andreas Pilarinos
Oral presentation
Does exposure to opioid substitution treatment in prison reduce the risk of death after release? A national prospective observational study in England
13:30
to
13:45
Central square 2 (C2)
John Marsden
Oral presentation
The off-prescription use of modafinil: an online survey of perceived risks and benefits
13:30
to
13:45
Insights zone 3 (I3)
Rachel Teodorini
Oral presentation
Constructing alcohol screening and counselling: the attitudes of social work professionals and their clients
13:30
to
13:45
Futures zone 3 (F3)
Elina Renko
13:40
Short communication
The impact of abused drugs spectrum among romanina IDU's on STI's, TB and blood born diseases in the last 10 years
13:40
to
13:50
Networking zone 3 (N3)
Adrian Abagiu
13:45
Oral presentation
Results of mortality cohort study of problem drug users in Poland.
13:45
to
14:00
Central square 2 (C2)
Janusz Sieroslawski
Oral presentation
Prospective cohort to assess the impact of removing non-prescription codeine in Australia
13:45
to
14:00
Insights zone 3 (I3)
Jacqui McCoy
Oral presentation
The who, what, where, when and why of adults’ drinking occasions and their association with acute alcohol-related harm: a systematic review
13:45
to
14:00
Futures zone 3 (F3)
Abigail Stevely
13:50
Short communication
Zero new infections of HIV among PWID, 4 consecutive years, a reality in Macau
13:50
to
14:00
Networking zone 3 (N3)
Augusto Nogueira
14:00
Short communication
Theory versus practice, bacteriological efficiency versus personal habits. A bacteriological and user acceptability evaluation of filtering tools for people who inject drugs.
14:00
to
14:10
Networking zone 3 (N3)
Marie Jauffret-Roustide
Oral presentation
Characteristics and problematic opioid use in people prescribed opioids for CNCP over four years: a prospective cohort study
14:00
to
14:15
Insights zone 3 (I3)
Gabrielle Campbell
Oral presentation
Harmony and dissonance in Swedish intoxication policy
14:00
to
14:15
Futures zone 3 (F3)
Oral presentation
Before rock bottom? Disrupting 'valid denial' amongst harmful drinkers with continuum beliefs
14:00
to
14:15
Futures zone 3 (F3)
James Morris
Oral presentation
Nasal naloxone for overdose prevention in Norway: results from the first four years
14:00
to
14:15
Central square 2 (C2)
Oral presentation
Nasal naloxone for overdose prevention in Norway: results from the first four years
14:00
to
14:15
Central square 2 (C2)
Desiree Eide
14:10
Short communication
C+ |Be+| Be your rights... an example of community mobilisation in a neighborhood with an open scene of drug consumption in Porto.
14:10
to
14:20
Networking zone 3 (N3)
Rui Miguel Coimbra Morais
14:15
Oral presentation
Incidence and predictors of drug overdoses among a cohort of patients treated for substance use disorder
14:15
to
14:30
Central square 2 (C2)
Birgitte Thylstrup
Oral presentation
A qualitative study of gabapentin use and misuse: perspectives of substance abuse treatment professionals
14:15
to
14:30
Insights zone 3 (I3)
Mance Buttram
Oral presentation
Alcohol policies in Portugal: stakeholders' evaluation
14:15
to
14:30
Futures zone 3 (F3)
Hilson Cunnha Filho
14:20
Short communication
Innovative practices in harm reduction outreach teams in the city of Lisbon
14:20
to
14:30
Networking zone 3 (N3)
Inês Costa
Cristiana Merendeiro
14:30
Oral presentation
MDMA-related deaths in Australia
14:30
to
14:45
Central square 2 (C2)
Amanda Roxburgh
15:00
Poster
Dosing of naloxone in opioid overdose outside of hospital. Observational data 2014 -18 in Oslo, Norway
15:00
to
16:30
Guided poster tours room
Ida Tylleskär
Poster
Increasing trend and differential patterns of opioids prescribing by patient characteristics in primary care in Belgium: a registry-based study
15:00
to
16:30
Guided poster tours room
Catharina Matheï
Poster
Patterns in analgesic opioids use in Germany and France: improved pain management and risks of misuse
15:00
to
16:30
Guided poster tours room
Jessica Neicun
Poster
Barriers to establishing take-home naloxone programmes
15:00
to
16:30
Guided poster tours room
Sibella Hare Breidahl
Poster
Patient characteristics and expected needs: an opioid substitution programme findings
15:00
to
16:30
Guided poster tours room
Catarina Oliveira
Poster
Benzodiazepine use among patients in opioid substituttion treatment: a cross sectional study
15:00
to
16:30
Guided poster tours room
Catarina Oliveira
Poster
Hospitalisation of children after prenatal exposure to Methadone and Buprenorphine: national registry study from Czechia
15:00
to
16:30
Guided poster tours room
Blanka Nechanská
Poster
Uncovering trajectories of satisfaction with injectable opioid agonist treatment for severe opioid use disorder
15:00
to
16:30
Guided poster tours room
Kirsten Marchand
Poster
Predicting pain intensity following discontinuation of long-term opioid therapy among patients with and without substance use disorders
15:00
to
16:30
Guided poster tours room
Crystal Smith
Poster
Addressing the opioid crisis: engagement in multidisciplinary care
15:00
to
16:30
Guided poster tours room
Tianna Magel
Poster
Comparing rates and characteristics of harms across different pharmaceutical opioids: an examination of Australian ambulance attendances 2013-2018
15:00
to
16:30
Guided poster tours room
Tina Lam
15:10
Oral presentation
Growing up in a context of parental substance use: adult children's lived experiences on attachment and intergenerational transmition of trauma
15:10
to
15:25
Networking zone 2 (N2)
Florien Meulewaeter
15:25
Oral presentation
Examining the pathways for young people with drug and alcohol dependence following residential treatment: a data linkage study
15:25
to
15:40
Networking zone 2 (N2)
Sally Nathan
Sarita Bista
15:40
Oral presentation
The relationship between drugs and crime from the perspective of young people in contact with criminal justice systems. A qualitative, cross-national research.
15:40
to
15:55
Networking zone 2 (N2)
Franca Beccaria
15:55
Oral presentation
Substance use among college students in the Netherlands: a closer look at the prevalence of use and risk perception
15:55
to
16:10
Networking zone 2 (N2)
Arne van den Bos
16:10
Oral presentation
Unfolding social and material practices of drug treatment for youth in Azerbaijan and Germany
16:10
to
16:25
Networking zone 2 (N2)
Aysel Sultan
16:50
Oral presentation
Modeling economical costs of alcohol consumption in Germany: the GECO-ALC1 project
16:50
to
17:05
Central square 3 (C3)
Jakob Manthey
17:00
Oral presentation
Which internalising disorders associate with harmful alcohol use in late adolescence and early adulthood?
17:00
to
17:15
Futures zone 2 (F2)
Gwen Fernandes
Oral presentation
Interpreting wastewater data alongside other population-level indicators of stimulant use
17:00
to
17:15
Central square 2 (C2)
Hayley Jones
17:05
Oral presentation
Estimating substance use costs and harms in Canada
17:05
to
17:20
Central square 3 (C3)
Matthew Young
17:15
Oral presentation
Is the relationship between use of high potency cannabis and mental health explained by frequency of cannabis use?
17:15
to
17:30
Futures zone 2 (F2)
Lindsey Hines
Oral presentation
What are the indirect causes of death among people who use drugs in Ireland? Findings from a comprehensive special register on drug related deaths
17:15
to
17:30
Central square 2 (C2)
Suzi Lyons
17:20
Oral presentation
Morbi-mortality consequences of misuse of psychoactive prescription drugs in Portugal: a retrospective observational study - the MisuMedPT project
17:20
to
17:35
Central square 3 (C3)
Ana Araújo
17:30
Oral presentation
Patterns of cigarette and cannabis use across adolescence and later cognition and emotional processing: improving causal inference
17:30
to
17:45
Futures zone 2 (F2)
Liam Mahedy
Oral presentation
Temporary and constant remission: a record-linkage study of a national cohort of people with psychoactive drug use disorders
17:30
to
17:45
Central square 2 (C2)
Morten Hesse
17:45
Oral presentation
Subclinical alcohol related liver disease in young people – below the surface
17:45
to
18:00
Futures zone 2 (F2)
Kushala Abeysekera
Oral presentation
Effective policies to support autonomous attempts to quit opioid use - a cross-sectional study across 14 countries
17:45
to
18:00
Central square 2 (C2)
Larissa Maier
Friday, 25 October
10:55
Short communication
Single-gender groups for women suffering from opioid use fisorder: theory and treatment
10:55
to
11:05
Networking zone 3 (N3)
Efrat Fridma
11:05
Short communication
Systematic monitoring and feedback on data results as supportive tools for substance use disorder individuals
11:05
to
11:15
Networking zone 3 (N3)
Thomas Solgård Svendsen
11:15
Short communication
Patient-centered care for addictions treatment: findings from a scoping review
11:15
to
11:25
Networking zone 3 (N3)
Kirsten Marchand
11:25
Short communication
OST futures: integrating the user’s experience into person-centred care
11:25
to
11:35
Networking zone 3 (N3)
Karen Black
11:35
Short communication
Telephone delivered incentives for encouraging adherence to supervised methadone (TIES): development and feasibility study
11:35
to
11:45
Networking zone 3 (N3)
Nicola Metrebian
11:45
Short communication
Benzodiazepine use in an opioide maintenance programme: risks and clinical outcomes
11:45
to
11:55
Networking zone 3 (N3)
Catarina Oliveira
11:55
Short communication
Telephone-delivered contingency management to promote behaviour change in addiction treatment.
11:55
to
12:05
Networking zone 3 (N3)
Carol-Ann Getty
12:05
Short communication
Measuring personality problems in patients with substance use disorders
12:05
to
12:15
Networking zone 3 (N3)
Espen Ajo Arnevik